Radium-223 dichloride (xofigo)
Ended Awarded Last action
- Contract number
- 36C25020N0201
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $173,824
Award facts
- Contract value 100% obligated
- $173,823.73 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$76,088 | |
| Original award | $249,912 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $173,823.73 firm fixed price blanket purchase agreement call contract to Bayer Healthcare Pharmaceuticals Inc. for the pharmaceutical RADIUM-223 DICHLORIDE (XOFIGO). Performance will occur in Indianapolis, Indiana and the contract is scheduled for completion by September 30, 2025. The award was made off the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with no set-aside designation specified. The contract will provide radium-223 dichloride drug products to support healthcare services for veterans within VISN 10, advancing the VA's mission of serving those who have served.
Quick answers
Who was awarded contract 36C25020N0201?
36C25020N0201 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on November 19, 2019.
How much is contract 36C25020N0201 worth?
The government has obligated $173,824 on 36C25020N0201.
Is contract 36C25020N0201 an order under another contract?
Yes. 36C25020N0201 is a BPA call under V797P2202D-36C25020A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25020N0201 competed?
The extent of competition for 36C25020N0201 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award